Atlas Trials

PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00048230 · COMPLETED

Trial details

NCT number
NCT00048230
Sponsor
Millennium Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2002-06-01
Primary completion
2004-07-01
Enrollment
620

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.